deltatrials
Completed OBSERVATIONAL NCT01454427

Influence of Anesthesia Drugs on Impedance Aggregometry

The Influence of Drugs Routinely Used in Cardiac Anesthesia on Impedance Aggregometry.

Sponsor: University of Lausanne Hospitals

Updated 9 times since 2017 Last updated: Oct 18, 2011 Started: Oct 31, 2010 Primary completion: May 31, 2011 Completion: May 31, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Platelet Dysfunction and is currently completed. University of Lausanne Hospitals leads this study, which shows 9 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshotCompleted~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshotCompleted~Apr 2018 – ~May 2018 · 30 days · monthly snapshotCompleted~May 2018 – ~Nov 2020 · 30 months · monthly snapshotCompleted~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Dec 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Dec 2021 [monthly]

    Completed

  5. Nov 2020 — Jan 2021 [monthly]

    Completed

Show 4 earlier versions
  1. May 2018 — Nov 2020 [monthly]

    Completed

  2. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NANone

  3. Aug 2017 — Apr 2018 [monthly]

    Completed NA

  4. Jan 2017 — Aug 2017 [monthly]

    Completed NA

    First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Lausanne Hospitals
Data source: University of Lausanne Hospitals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations